Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity
Human Psychopharmacology: Clinical and Experimental · 2024
DOI: 10.1002/hup.2913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2024. Verfasst von Emre Sarandol und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Departments of Medical Biochemistry, Bursa Uludag Universitiy, Bursa, Turkey. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Obesity, Oxidative Stress. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Bursa Uludağ Üniversitesi.
Abstract (Originalsprache)
Objective
To define the impact of obesity on inflammatory and oxidative disturbances in antipsychotic‐treated schizophrenia patients.
Methods
Several cytokines, inflammatory, metabolic, and oxidative status markers were evaluated in obese ( n = 40) and non‐obese ( n = 40) antipsychotic‐treated patients and compared with age‐and BMI‐matched controls ( n = 80).
Results
Schizophrenia patients had higher leptin, TNF‐α, adiponectin, visfatin, resistin, P‐selectin, NPY, BDNF, CD40‐L, MCP‐1, and malondialdehyde, and lower IL‐6, ghrelin, neopterin, and vitamin E levels compared to their respective controls ( p < 0.001). Total oxidant status was higher in non‐obese patients compared to controls ( p < 0.001), total antioxidant capacity was higher in obese compared to non‐obese patients ( p < 0.01), but vitamin A and paraoxonase levels were not different. High sensitive‐CRP levels were higher in obsese controls relative to non‐obese controls ( p < 0.05) and in obese patients relative to non‐obese patients ( p < 0.001). Fasting glucose, insulin, HbA1c, HOMA‐IR, uric acid, total cholesterol, and triglyceride concentrations were higher in obese patients compared to non‐obese patients. Insulin concentrations and HOMA‐IR were also higher in obese controls than in non‐obese controls.
Conclusions
Our results suggest that inflammatory responses and oxidative stress develop independently from obesity in antipsychotic‐treated schizophrenia patients. However, schizophrenia‐induced obesity causes metabolic disturbances; thereby, obese schizophrenia patients are more liable to cardiovascular events and progress of metabolic syndrome than non‐obese patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Faculty, Departments of Medical Biochemistry, Bursa Uludag Universitiy, Bursa, Turkey.
- Medical Faculty, Departments of Psychiatry, Bursa Uludag Universitiy, Bursa, Turkey.
ORCID-Profile: Emre Sarandol, Asli Sarandol, Sener Mercan, Salih Saygin Eker, Esma Surmen-Gur
Förderung
- Bursa Uludağ Üniversitesi
Zitieren
APA
Sarandol, E., Sarandol, A., Mercan, S., Eker, S. S., & Surmen-Gur, E. (2024). Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2913
Vancouver
Sarandol E, Sarandol A, Mercan S, Eker SS, Surmen-Gur E. Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity. Human Psychopharmacology: Clinical and Experimental. 2024. doi:10.1002/hup.2913
BibTeX
@article{Sarandol2024,
author = {Sarandol, Emre and Sarandol, Asli and Mercan, Sener and Eker, Salih Saygin and Surmen-Gur, Esma},
title = {Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2024},
doi = {10.1002/hup.2913}
}
EUVIMED